Showing results (1261-1270 of 1,547) with videos related to

Sort By:
Pageof 155
Neuro-Oncology|May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challengesMichael D Prados, Sara A Byron, Nhan L Tran, et al.
Neuro-Oncology Practice|July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiativeLinda Dirven, Maartje E Vos, Tobias Walbert, et al.
Neuro-Oncology|June 26, 2021
Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumorsJian Peng, Daniel D Kim, Jay B Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.
Neuro-Oncology|July 22, 2025
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspectiveMartin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson, et al.
JAMA|February 19, 2026
Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical TrialAyal A Aizer, Kee-Young Shin, Paul J Catalano, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupNancy U Lin, Jeffrey S Wefel, Eudocia Q Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Neuro-Oncology Advances|February 16, 2026
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitorsVihang Nakhate, Catharina Westergaard, Zhou Lan, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Pageof 155